BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
1/21/22 UCB (UCB) Bimekizumab for Psoriatic Arthritis (PA) Subscribers Only Subscribers Only Subscribers Only
1/19/22 Sanofi (SNY) Dupixent for Pruritus Subscribers Only Subscribers Only Subscribers Only
1/18/22 AstraZeneca (AZN) Imfinzi for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) Subscribers Only Subscribers Only Subscribers Only
1/18/22 ImmunityBio (IBRX) Anktiva for Pancreatic Cancer Subscribers Only Subscribers Only Subscribers Only
1/18/22 Exelixis (EXEL) Cabometyx / Cometriq for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
01/22/22 Subscribers Only Subscribers Only Trial Data - Updated Results
01/22/22 Subscribers Only Subscribers Only Trial Data - Updated Results
01/24/22 Subscribers Only Subscribers Only Regulatory - Meeting with FDA
01/25/22 Subscribers Only Subscribers Only Patent - Expiration
01/25/22 Subscribers Only Subscribers Only Trial Data - Updated Results
Back to the top Back to the top